<List><item><source>MED</source><extId>20509714</extId><pmcid>PMC3585687</pmcid><annotations><annotation><prefix>double-blind trial (</prefix><exact>NCT00314951</exact><postfix>), the efficacy and </postfix><tags><tag><name>NCT00314951</name><uri>http://identifiers.org/clinicaltrials/NCT00314951</uri></tag></tags><id>http://europepmc.org/articles/PMC3585687#europepmc-25781d5f4a59fb67fdaec2767bd1812a</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>al phase III trial (</prefix><exact>NCT00468728</exact><postfix>), having an identic</postfix><tags><tag><name>NCT00468728</name><uri>http://identifiers.org/clinicaltrials/NCT00468728</uri></tag></tags><id>http://europepmc.org/articles/PMC3585687#europepmc-dd34e0ed391fa29b7df4aaf078612cb7</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>